These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

867 related items for PubMed ID: 8272155

  • 1. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O, Mesárosová A, Koníková M, Kusenda J, Glasová M, Klobusická M.
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [Abstract] [Full Text] [Related]

  • 2. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G, Coustan-Smith E, Campana D.
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [Abstract] [Full Text] [Related]

  • 3. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996 Mar; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 4. Phenotypic heterogeneity and aberrant markers expression in T-cell leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J, Cáp J, Gyárfás J, Koubek K.
    Neoplasma; 1998 Mar; 45(3):128-34. PubMed ID: 9717523
    [Abstract] [Full Text] [Related]

  • 5. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 6. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A, Babusíková O.
    Neoplasma; 2001 Apr; 48(3):164-8. PubMed ID: 11583283
    [Abstract] [Full Text] [Related]

  • 7. Human hematopoietic cell lines: a model system for study of minimal residual disease detection technique in acute leukemia.
    Koníková E, Kusenda J, Babusíková O, Glasová M.
    Neoplasma; 1995 Apr; 42(5):227-34. PubMed ID: 8552200
    [Abstract] [Full Text] [Related]

  • 8. [Cellular immunophenotypes in 97 adults with acute leukemia].
    Piedras J, López-Karpovitch X, Cárdenas MR.
    Rev Invest Clin; 1997 Apr; 49(6):457-64. PubMed ID: 9528305
    [Abstract] [Full Text] [Related]

  • 9. The relationship between argyrophilic proteins and some immunophenotypic markers in acute leukemia cells.
    Klobusická M, Babusíková O.
    Neoplasma; 1997 Apr; 44(6):356-60. PubMed ID: 9605007
    [Abstract] [Full Text] [Related]

  • 10. Flow cytometric determination of leukemia-associated marker combinations for the study of minimal residual disease.
    Babusíková O, Glasová M, Kusenda J, Koníková E, Mésárosová A.
    Neoplasma; 1994 Apr; 41(6):305-13. PubMed ID: 7870213
    [Abstract] [Full Text] [Related]

  • 11. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
    Nakase K, Kita K, Miwa H, Nishii K, Shiku H, Nasu K, Dohy H, Kyo T, Kamada N, Tsutani H.
    Cancer Detect Prev; 2001 Apr; 25(4):394-405. PubMed ID: 11531016
    [Abstract] [Full Text] [Related]

  • 12. Intracellular markers in acute myeloid leukemia diagnosis.
    Koníková E, Glasová M, Kusenda J, Babusíková O.
    Neoplasma; 1998 Apr; 45(5):282-91. PubMed ID: 9921916
    [Abstract] [Full Text] [Related]

  • 13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Apr; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 14. Prognostic value of cell marker analysis in de novo acute myeloid leukemia.
    Del Poeta G, Stasi R, Venditti A, Suppo G, Aronica G, Bruno A, Masi M, Tabilio A, Papa G.
    Leukemia; 1994 Mar; 8(3):388-94. PubMed ID: 7907393
    [Abstract] [Full Text] [Related]

  • 15. [Flow cytometric analysis of myeloperoxidase negative acute unclassifiable leukemias by monoclonal antibodies. Acute myelogenous and acute megakaryocytic leukemia].
    Imamura N, Kuramoto A, Kawaguchi Y, Tanaka R.
    Rinsho Ketsueki; 1989 Jan; 30(1):11-21. PubMed ID: 2541276
    [Abstract] [Full Text] [Related]

  • 16. Analysis of myeloid and lymphoid markers on the surface and in the cytoplasm of mononuclear bone marrow cells in patients with myelodysplastic syndrome.
    Schlesinger M, Silverman LR, Jiang JD, Yagi MJ, Holland JF, Bekesi JG.
    J Clin Lab Immunol; 1996 Jan; 48(4):149-66. PubMed ID: 9819667
    [Abstract] [Full Text] [Related]

  • 17. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
    Liu YR, Wang YZ, Chen SS, Chang Y, Fu JY, Li LD, Wang H, Yu H, Jiang B, Huang XJ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
    [Abstract] [Full Text] [Related]

  • 18. Myeloid enzymes profile related to the immunophenotypic characteristics of blast cells from patients with acute myeloid leukemia (AML) at diagnosis.
    Klobusicka M, Kusenda J, Babusikova O.
    Neoplasma; 2005 Nov; 52(3):211-8. PubMed ID: 15875082
    [Abstract] [Full Text] [Related]

  • 19. [Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping of leukemias].
    Piedras J, Barrales-Benítez O, López-Karpovitch X.
    Rev Invest Clin; 2000 Nov; 52(5):524-8. PubMed ID: 11195181
    [Abstract] [Full Text] [Related]

  • 20. Immunophenotypic characteristics of T-acute lymphoblastic leukemia cells in relation to DPP IV enzyme expression.
    Klobusická M, Babusíková O.
    Neoplasma; 1998 Nov; 45(4):237-42. PubMed ID: 9890667
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.